utilized or results not indicated to show where the mean values between two groups differed.
6. It would be helpful to include in tables 1 and 2 the distribution by nap and sleep category. The sample size is already shown, the % should be added to give the reader a sense of the distribution.
7. The results section for table 2 is quite limited, one sentence only. Include some of the variables, specifically the outcome variables and confounders.
8. In table 3 model c, it's unclear why the model was adjusted for FBG since it is part of the definition of IGR. Were analyses of IGR and FBG run separately and if so what was the result of that analysis. Might be helpful to indicate in the text the rationale for combining both since they are known to have differing pathways.
9. The last sentence in the first paragraph of the discussion section reads, "Furthermore, increased BMI and WHR (abdominal obesity) in nappers seemed to somewhat explain those associations." Can you please explain this reasoning? WHR and BMI were added in the model with a number of other variables at the same time so how was their independent contribution assessed?
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GENERAL COMMENTS
In this cross-sectional study, H. Lin and colleagues examining the associations between sleep habits -both nighttime sleep duration and napping habits -with multiple metabolic and other measures in a very large cohort of Chinese adults.
This study has a number of strengths, including large sample size, multiple measures of glycemia (OGTT and HbA1C both) and other metabolic syndrome and related components, including lipids and fasting insulin levels. They also collected other relevant information, such as degree of total and central obesity, smoking and other potential confounders, and accounted for them in the regression analysis. The article is also well-written.
However, this study has several weaknesses which should be addressed. The biggest overall critique is that the difference between statistical significance and clinical significance is not adequately addressed. Many of the results presented, especially in table 1 and table 2 , showcase differences which are statistically significant but clinically marginal.
Otherwise, a quick grammatical review would be in place -there are a few mis-placed commas and places of tense disagreement.
Section-by-section critiques are included below:
A. ABSTRACT: "Nappers were older males" is overly stating the study results. Nappers trended towards being slightly older than non-nappers -but that was a difference of 0.1 year between non-nappers and nappers of <=1 hr, and 0.7 year between the first and second group of nappers. This is an excellent example of statistically significant but clinically non-significant differences. Also, while there were a higher proportion of males in the napping than non-napping groups, females were still the more numerous in each group. This sentence should be rephrased to match the results -something like "the proportion of males was higher in the napping than non-napping groups". The rest of the abstract result detailing differences between nappers and non-nappers includes multiple other results which were statistically significant but clinically marginal between the groups: SBP, fasting glucose, HbA1C, fasting insulin, HDL. See more details in the results section critique below -but the abstract should be rewritten to clarify which results were clinically significant vs. only statistically difference between the groups.
B. INTRODUCTION:
-Reference #1 quoted to support decline in sleep duration over the past few decades. This is an excellent example of "be careful what reference you quote". While this study does (if the reader does some arithmetic) describe the amount by which sleep has declined (in different populations), its main thrust is that the optimal amount of sleep is not well-established; the authors even state "that the population as a whole should sleep more is not supported by our data".
Otherwise, there are no significant problems in the introduction METHODS -Minor grammatical edits necessary -e.g. extraneous commas (e.g. page 5 line 24), tense agreement (page 6 line 1).
-How was waist circumference measured? There are at least 3 different ways of measurements to be found in the literature (level of umbilicus, natural waist, midway between lower rib and iliac crest). Was the way in which waist circumference was measured standardized? How was hip circumference measured? Please explain and give citations. Also, why was WHR chosen over WC as the measure of central adiposity? There are papers one could cite to support this choice (or the converse choice) -but some explanation should be given.
-Were snoring habits reported by patients or by their spouses/significant others? The latter is more accurate? Also, what sleep questionnaires were used? Were these questionnaires validated? More information is necessary, since this is one of the main outcomes measures of this study.
-The WHO guidelines cited in reference 11 are outdated -two revisions have come out since then. The most recent update, in 2011, was revised to include HbA1C; this update should be cited, not the very old version cited here.
-How was the cut-point of HbA1C (<6.0%) chosen? The WHO (whose criteria for IFG and DM are cited earlier in preference to the ADA's) only considers HbA1C >6.5% as abnormal; for that matter, the ADA no longer uses a cutoff of 6.0% for anything (prediabetes is now 5.7-6.4 and T2DM is HbA1C >=6.5%). If the authors wish to use a cutoff HbA1C of 6.0%, that is their prerogative, but they should either find a reference to cite which shows that A1C of >=6.0% predicts CVD, or else cite a different reason for this cutoff choice. For example, if the HbA1C cutoff came from the UK Best Practice Guidance from the Department of Health, then that's fine -but this needs to be stated and a citation provided.
-Reference #14 is cited to support that statement that "HbA1c >6.0% was applied as an independent predictor of subsequent cardiovascular disease in non-diabetic middle-aged adults [14] ." However, the article cited does not support the statement. This article found that those with higher AHI (i.e. obstructive sleep apnea) had a higher odds ratio of having a HbA1C >6, but the article did not address the question of predicting CVD.
Statistical analysis comments:
-Clinical data were presented as mean ± SD or percentage. However, median (interquartile range) should be used instead of mean ± SD for all non-normally distributed data. Since some data were not normally distributed by the authors' report that nonparametric testing was sometimes used, (though it was not clear in -While there is a trend in differing fasting plasma glucose levels among the three groups, a difference in glucose of <5 mg/dL (0.28 mmol/L) is not considered clinically significant. Also, the trend in the fasting glucoses is the reverse of the trend seen with the 2-hr glucoses and HbA1C levels.
-The trend in 2-hr glucose differences was consistent and (at least vis-à-vis the difference between >1 hr nappers vs. non-nappers) somewhat clinically meaningful.
-While the trend in Hba1C between groups is consistent with the trend in the 2-hr glucose levels (though not the fasting glucose trends), the differences in actual HbA1C values -5.61% vs. 5.65% vs. 5.67% -are marginal.
-The trend for fasting insulin is consistent with the HbA1C-2-hr glucose trend above, but again, the actual inter-group differences are marginal -The difference in HOMA-IR between the non-nappers and the napping groups is at least somewhat meaningful; the differences between napping groups is not meaningful.
-The HDL and triglyceride trends paralleled each other (and that of most of the other trends above); however, the HDL differences were marginal. The TG differences between non-nappers and nappers were clinically meaningful; the differences between <=1 vs. >1 hr napping groups were clinically marginal.
-The differences in WHR were clinically marginal (0.86 vs. 0.87 vs. 0.87) -Nappers tended to have shorter night-time sleep duration than nonnappers.
-The longest nappers were likelier to snore than the <1 hrs nappers and the non-nappers. This definitely bears mentioning as a confounder.
Overall critique for table 2: Overall critique is similar to comments for table 1 -there are too many different sub-groups being compared, so odds are good that some group's results will stand out as different. At the very least, comparisons between several individual sub-groups (reference population vs. long sleepers and ref population vs. short sleepers (<8 hrs, or even 6-8 hrs and <6 hrs) and long vs. short sleepersshould be done.
-Most of the differences depicted as significant between groups, including DBP, FPG, fasing insulin, HDL, WHR, BMI, and HbA1C -are statistically significant but clinically marginal (and not necessarily consistent in one direction or another). The SBP trended towards a meaningful difference 0 between the >9 hrs sleepers and the <8 hrs sleeprs collectively only. The HOMA-IR difference between the longest/shortest sleepers vs. 6-8 hr sleepers may meet clinical significance, when grouped as such only.
A few problems with 4. The HOMA-IR results, with increased odds in nappers vs. nonnappers, are convincing. However, the IGR and to a lesser the HbA1C results are somewhat less convincing -it seems that there were not significant trends until the 3rd or 4th level of regression analysis. Could it be that the final models are overly specified? The authors have the power with the sample size, but not the change in the results from non-significant to significant suggests that the differences are due to the confounding variables included in the models rather than to intrinsic differences between the groups.
Other non-table critiques for this section: -The third sentence (page 8 line 8) states that "Compared with the no nap group, nappers (≤1 or >1 h of napping) were older males". This is poorly phrased. There was a higher percentage of males in the napping groups, but the percentage of females vs. males was higher in all study groups.
-There is a discrepancy between the regression analysis as reported in the body of the manuscript, which included night-time sleep duration in the napping analyses and nap status in the sleep duration analyses, and the analyses reported in the text accompanying the table, which makes no mention of sleep duration/nap status adjustments. This discrepancy should be reconciled.
D. DISCUSSION:
The overall critique stems from the critiques in the results sectionthat the differences between groups may have been more statistically significant than clinically significant, and that some of the differences observed in HbA1C and IGR (though not in IR status) may have been more related to the confounding factors than to the naps themselves. More specific comments vis-à-vis the discussion section are not useful until this one large issue is addressed. This should be emphasized more. In general, it seems that there are trends towards differences which may point towards higher future risk of diabetes in adult Chinese who nap; either longitudinal studies or studies comparing napping habits of diabetic vs. non-diabetic adults would need to be done to confirm clinical significance.
Other comments: -The sentence "subjects with shorter nighttime sleep (<6 h, ≥6 to <7 h or ≥7 to <8 h) had HbA1c >6.0% and IGR compared with these values in persons reporting ≥8 to <9 h of nighttime sleep after adjusting for several potential confounding factors" is poorly phrased. A more accurate depiction would be that subjects with shorter sleep "were more likely to have HbA1C >6.0% and more likely to have IGR" -Snoring is stated to be a surrogate for OSA (though not insomnia) without a reference. A reference should be provided.
-Continuing along the snoring theme: While there is an association between self-reported snoring and OSA, it is not a 1:1 association, and self-reported snoring is less accurate than spouse-reported snoring. Therefore, it is still quite possible that some of the differences between sleep groups may be attributed to either OSA or to insomnia -the snoring inclusion in the regression model helps to address this question, but cannot fully answer it. The authors should state that future studies examining this question should also include polysomnography data.
VERSION 1 -AUTHOR RESPONSE
Reviewer comment:
The abstract does not include the exposure variable, napping and sleep duration, except to say it was collected using a questionnaire. Was the questionnaire standardized, or how was the question posed? Consider omitting "prospective" from the design designation. Author response:The questionnaire was originally part of an epidemiological study on the risk of comorbidities for type 2 diabetes mellitus patients in China. It was standardized and in the Chinese language with simple, direct questions about the respondents' sleep, including duration, frequency and quality of sleep. We adapted that questionnaire for the present study, eliminating inappropriate questions. We have deleted the word "prospective" from the study design as requested. Reviewer comment:
The cut point for HOMA-IR was 2.5.What is the basis for this cutpoint? The mean HOMA-IR levels by napping groups in Table 1 ranged from 1.49 to 1.63, and the range among overnight sleep categories ranged from 1.5 to 1.61, well below the cutpoint used. Author response: We used a previous study as the basis for establishing a cut point, which defined IR as HOMA-IR values >2.50 (Wang et al. 2012, #14) . Our subject population were non-diabetic adult Chinese; with these results, we must expect that they would not have IR.
Reviewer comment: It will be helpful to the reader to include the % of subjects above/below he cutpoint for each of the outcome variables and include this information in the tables. Author response: We have added the percentages as recommended by the reviewer. Now all categorical variables are presented as count and percentage in Tables 1 and 2. Reviewer comment: I'm presuming that the pvalues in tables 1 and 2 were from the analysis of variance and not a p value for trend. In the methods section, the authors indicate that the In the revised model c in Table 3 , FBG was excluded since it is part of the definition of IGR as suggested. We adjusted for FBG separately as one factor of IGR. We did not "combine" FBG and IGR for the reasons mentioned. These adjustments of variables are correctly applied as described in the footnote of Table 3 .
The last sentence in the first paragraph of the discussion section reads, "Furthermore, increased BMI and WHR (abdominal obesity) in nappers seemed to somewhat explain those associations." Can you please explain this reasoning? WHY and BMI were added in the model with a number of other variables at the same time so how was their independent contribution assessed? Author response: With the revisions that have been made to the text and tables in order to satisfy reviewers' comments, this sentence is now irrelevant. We have deleted it accordingly.
Reviewer comment: Please state any competing interests of state "None declared." Author response: The competing interests statement was included in "Acknowledgements" in the original manuscript. We now show a separate heading for conflict of interest, stating "None" as advised.
Reviewer comment: A quick grammatical review would be in place -there are a few mis-placed commas and places of tense disagreement. Author response: After our recent revisions and updates, the entire report was edited by a professional medical editor whose native language is English. We believe it is in good English throughout.
Reviewer comment: Many of the results presented, especially in table 1 and table 2 , showcase differences which are statistically significant but clinically marginal. Author response: We did observe this but did not address it previously. We have revised text as needed (in Results and Discussion) to acknowledge that some significant differences were not clinically significant. Please see the revised Results and Discussion sections. Because our analysis had sufficient power due to the large sample, we do not believe that this is a limitation of the study, but we do believe, as reviewers have suggested, that readers should understand differences may be significant in the context of grouping of subjects but may not be clinically meaningful in terms of subjects' health status.
Reviewer comment: ABSTRACT: "Nappers were older males" is overly stating the study results. Nappers trended towards being slightly older than non-nappers -but that was a difference of 0.1 year between non-nappers and nappers of <=1 hr, and 0.7 year between the first and second group of nappers. This is an excellent example of statistically significant but clinically non-significant differences. Also, while there were a higher proportion of males in the napping than nonnapping groups, females were still the more numerous in each group. This sentence should be rephrased to match the results -something like "the proportion of males was higher in the napping than non-napping groups". Author response: The updating of the tables has helped with this issue and we have also revised text as needed to more carefully interpret results. We have adopted the suggested wording of specific results and have tried to avoid overstating the results in the Results section as well. Please see the revised Abstract and revised Results section.
The rest of the abstract results detailing differences between nappers and non-nappers includes multiple other results which were statistically significant but clinically marginal between the groups: SBP, fasting glucose, HbA1C, fasting insulin, HDL. See more details in the results section critique below -but the abstract should be re-written to clarify which results were clinically significant vs. only statistically difference between the groups. Author response: Again, we have tried to include acknowledgement of the statistically significant differences between groups that may not be clinically significant. The Abstract has a strict word limit so we cannot be specific regarding all results, we can only state it generally to make readers aware.
Reviewer comment: INTRODUCTION: Reference #1 quoted to support decline in sleep duration over the past few decades. This is an excellent example of "be careful what reference you quote". While this study does (if the reader does some arithmetic) describe the amount by which sleep has declined (in different populations), its main thrust is that the optimal amount of sleep is not well-established; the authors even state "that the population as a whole should sleep more is not supported by our data." Author response: Regarding the cited reference, we have explained it more carefully in the revised text and pointed out the fact that the study did not actually support that all adults require more sleep. Please see the revised Introduction.
Reviewer comment: Minor grammatical edits necessary -e.g. extraneous commas (e.g. page 5 line 24), tense agreement (page 6 line 1). Author response: We have corrected those specific language and punctuation issues. Also, as stated above, after our recent revisions and updates, the entire report was edited by a professional medical editor whose native language is English. We believe it is in good English throughout.
Reviewer comment: How was waist circumference measured? There are at least 3 different ways of measurements to be found in the literature (level of umbilicus, natural waist, midway between lower rib and iliac crest). Was the way in which waist circumference was measured standardized. How was hip circumference measured? Please explain and give citations. Also, why was WHR chosen over WC as the measure of central adiposity? There are papers one could cite to support this choice (or the converse choice) -but some explanation should be given. Author response: Waist circumference was measured at the level of the umbilicus and hip circumference at the widest part of the buttocks according to standardized World Health Organization (WHO) criteria and the recommendations of expert consultation. There was no particular reason for choosing WHR over WC as the measure of central adiposity and, since we had both measurements, we thought that the ratio was more convincing. We cited the WHO expert consultation document for these measurements and it is included as #11 in the reference list.
Reviewer comment: Were snoring habits reported by patients or by their spouses/significant others? The latter is more accurate? Also, what sleep questionnaires were used? Were these questionnaires validated? More information is necessary, since this is one of the main outcomes measures of this study. Author response: The questionnaire was originally part of an epidemiological study on the risk of comorbidities for type 2 diabetes mellitus patients in China. It was standardized and in the Chinese language with simple, direct questions about the respondents' sleep, including duration, frequency and quality of sleep, which was the relevant portion we adopted for the present study. It is not a standardized sleep questionnaire per se. Snoring questions were actually in the respiratory part of the questionnaire but were applied appropriately into the snoring portion of the questionnaire we used (Example: Presence of snoring during sleeping within past 12 months: Often, Occasionally, Never, Unknown).
The WHO guidelines cited in reference 11 are outdated -two revisions have come out since then.
The most recent update, in 2011, was revised to include HbA1C; this update should be cited, not the very old version cited here. Author response: We have cited the most recent WHO guidelines accordingly.
Reviewer comment: -How was the cut-point of HbA1C (<6.0%) chosen? The WHO (whose criteria for IFG and DM are cited earlier in preference to the ADA's) only considers HbA1C >6.5% as abnormal; for that matter, the ADA no longer uses a cutoff of 6.0% for anything (prediabetes is now 5.7-6.4 and T2DM is HbA1C >=6.5%). If the authors wish to use a cutoff HbA1C of 6.0%, that is their prerogative, but they should either find a reference to cite which shows that A1C of >=6.0% predicts CVD, or else cite a different reason for this cutoff choice. For example, if the HbA1C cutoff came from the UK Best Practice Guidance from the Department of Health, then that's fine -but this needs to be stated and a citation provided.
Author response: The reference we originally cited was included in error and we have corrected our mistake. We have cited the recent WHO guidelines (#12) that included HbA1c as well as a fairly recent study as references for the HbA1c cut off of <6.0% (Selvin et al. 2010, #10) .
Reviewer comment: Reference #14 is cited to support that statement that "HbA1c >6.0% was applied as an independent predictor of subsequent cardiovascular disease in non-diabetic middle-aged adults [14] ." However, the article cited does not support the statement. This article found that those with higher AHI (i.e. obstructive sleep apnea) had a higher odds ratio of having a HbA1C >6, but the article did not address the question of predicting CVD. Author response: As we explained above, we inadvertently cited the wrong reference, meaning to cite Selvin et al. (2010) . We have corrected that mistake.
Reviewer comment: Statistical analysis comments:Clinical data were presented as mean ± SD or percentage. However, median (interquartile range) should be used instead of mean ± SD for all non-normally distributed data. Since some data were not normally distributed by the authors' report that nonparametric testing was sometimes used, (though it was not clear in Reviewer comment: Finally, given the large sample size and the large number of comparisons, an adjustment should be made for multiple hypothesis testing (e.g. Bonferroni correction).
Author response:Yes, we agree. The Bonferroni correction was used for multiple comparisons.
Reviewer comment: Overall critiques for Table 1 : P-value for differences between individual groups (i.e. nappers of <1 hr and >1 hr as well as non-nappers and <=1 hr nappers, and between nonnappers and >1 hr nappers) should be provided. If this makes the table too busy, I would be content with differences between the two napping groups in addition to overall ANOVA. A more substantial critique: Table 1 provides a number of good examples of the differences between statistical significance and clinical significance. The difference between a mean age of 50.9 ± 7.0 yrs (no nap group) vs. 51.0 yrs ± 7.0 years (<=1 hr nap) may be statistically significant with such a large sample group, but it is certainly not a meaningful difference clinically. Even the difference between 51.6 ± 7.0 years vs. the other two age brackets is, while more notable, not a particularly large difference. A better way to explain this is that subjects in the longer (>1 hr) napping group were slightly older. The mean differences in SBP -131.9 vs. 130.0 vs. 130.1 -are slightly different -perhaps statistically significant, but it's hard to make a claim for a significant difference between 131.9 vs. 130, let alone for between 130.1 and 130.04 mm Hg. While there is a trend in differing fasting plasma glucose levels among the three groups, a difference in glucose of <5 mg/dL (0.28 mmol/L) is not considered clinically significant. Also, the trend in the fasting glucoses is the reverse of the trend seen with the 2-hr glucoses and HbA1C levels. The trend in 2-hr glucose differences was consistent and (at least vis-à-vis the difference between >1 hr nappers vs. non-nappers) somewhat clinically meaningful.
-The trend for fasting insulin is consistent with the HbA1C-2-hr glucose trend above, but again, the actual inter-group differences are marginal The difference in HOMA IR between the nappers and the napping groups is at least somewhat meaningful; the differences between napping groups is not meaningful. The HDL and triglyceride trends paralleled each other (and that of most of the other trends above); however, the HDL differences were marginal. The TG differences between non-nappers and nappers were clinically meaningful; the differences between <=1 vs. >1 hr napping groups were clinically marginal.
-The differences in WHR were clinically marginal (0.86 vs. 0.87 vs. 0.87) -Nappers tended to have shorter night-time sleep duration than non-nappers. The longest nappers were likelier to snore than the <1 hrs nappers and the non-nappers. This definitely bears mentioning as a confounder. Author response:
Thank you for these detailed comments, which we had observed but had not discussed in the original text. The reviewer correctly points out that some of the parameters/confounders were statistically significant but were not clinically significant or meaningful in the sense of representing participants' health status. Differences were only marginal in some instances and we have revised the manuscript to reflect this where it applies, primarily in the Results section of the Abstract, in the main Results section and at greater length in the Discussion where interpretation should be presented, rather than in Results, which we present as they were observed without interpretation.
Reviewer comment: Table 2 : Overall critique is similar to comments for table 1 -there are too many different sub-groups being compared, so odds are good that some group's results will stand out as different. At the very least, comparisons between several individual sub-groups (reference population vs. long sleepers and ref population vs. short sleepers (<8 hrs, or even 6-8 hrs and <6 hrs) and long vs. short sleepersshould be done. Most of the differences depicted as significant between groups, including DBP, FPG, fasing insulin, HDL, WHR, BMI, and HbA1C -are statistically significant but clinically marginal (and not necessarily consistent in one direction or another). The SBP trended towards a meaningful difference 0 between the >9 hrs sleepers and the <8 hrs sleeprs collectively only. The HOMA-IR difference between the longest/shortest sleepers vs. 6-8 hr sleepers may meet clinical significance, when grouped as such only.
Author response: We agree that grouping by hours can be simplified and we have made this revision, including nighttime sleep groups as <6, 6-8, and >8 in all tables. As we responded above to similar comments about differences that were statistically significant but not clinically meaningful, we have revised text and added this point to the Abstract, in the main Results section and at greater length in the Discussion where interpretation should be presented, rather than in Results, which we present as they were observed without interpretation.
